A detailed history of Eagle Health Investments LP transactions in United Therapeutics Corp stock. As of the latest transaction made, Eagle Health Investments LP holds 179,499 shares of UTHR stock, worth $57.2 Million. This represents 7.66% of its overall portfolio holdings.

Number of Shares
179,499
Previous 170,838 5.07%
Holding current value
$57.2 Million
Previous $37.6 Million 9.77%
% of portfolio
7.66%
Previous 7.63%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$210.76 - $249.51 $1.83 Million - $2.16 Million
8,661 Added 5.07%
179,499 $41.2 Million
Q2 2023

Aug 14, 2023

BUY
$205.19 - $232.99 $8.13 Million - $9.23 Million
39,600 Added 30.17%
170,838 $37.7 Million
Q4 2022

Feb 13, 2023

SELL
$205.95 - $280.43 $1.96 Million - $2.66 Million
-9,500 Reduced 6.75%
131,238 $36.5 Million
Q3 2022

Nov 14, 2022

SELL
$203.3 - $244.17 $3.76 Million - $4.52 Million
-18,500 Reduced 11.62%
140,738 $29.5 Million
Q1 2022

May 12, 2022

BUY
$166.16 - $213.96 $963,728 - $1.24 Million
5,800 Added 3.78%
159,238 $28.6 Million
Q4 2021

Feb 10, 2022

BUY
$184.32 - $216.08 $10.2 Million - $12 Million
55,400 Added 56.51%
153,438 $33.2 Million
Q2 2021

Jul 19, 2021

BUY
$170.47 - $211.93 $841,780 - $1.05 Million
4,938 Added 5.3%
98,038 $17.6 Million
Q1 2021

Apr 23, 2021

BUY
$153.94 - $174.85 $3.56 Million - $4.04 Million
23,100 Added 33.0%
93,100 $15.6 Million
Q4 2020

Feb 04, 2021

BUY
$101.87 - $151.79 $7.13 Million - $10.6 Million
70,000 New
70,000 $10.6 Million

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $14.5B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Eagle Health Investments LP Portfolio

Follow Eagle Health Investments LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eagle Health Investments LP, based on Form 13F filings with the SEC.

News

Stay updated on Eagle Health Investments LP with notifications on news.